Literature DB >> 7819339

Regulated cleavage of the Alzheimer amyloid precursor protein: molecular and cellular basis.

S Gandy1, P Greengard.   

Abstract

The relative utilization of alternative processing pathways for APP can be regulated by the activation state of certain protein phosphorylation signal transduction pathways. For example, activation of protein kinase C (PKC), or inactivation of protein phosphatases 1 and 2A, leads to a relative increase in utilization of the nonamyloidogenic, 'alpha-secretase' cleavage pathway for APP processing at the expense of other pathways. The molecular and cellular basis for this regulatory event is unknown. The possible mechanisms of regulated APP cleavage include (either singly or in combination): 1) substrate (ie APP) activation; 2) substrate redistribution; 3) enzyme (ie alpha-secretase) activation; or 4) enzyme redistribution. APP is a phosphoprotein; however, recent evidence from studies of the metabolism of mutant APP molecules suggests that changes in the APP cytoplasmic tail phosphorylation state may not be necessary for the phosphorylation-dependent activation of 'alpha-secretase' cleavage. Further, indirect immunofluorescent studies of the subcellular distribution of APP in the absence or presence of phorbol esters (PKC activators) fail to disclose obvious phorbol-induced redistribution of APP immunoreactivity. Taken together, current data suggest that major candidate phosphorylation-state sensitive targets relevant to the molecular basis of PKC-activated processing (or 'regulated cleavage') of APP include the APP ectodomain as well as secretase enzymes and/or other components of the APP trafficking/processing apparatus. Progress in distinguishing among these possibilities is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819339     DOI: 10.1016/0300-9084(94)90162-7

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  13 in total

1.  Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Laszlo Zaborszky
Journal:  Neuroscientist       Date:  2015-05-22       Impact factor: 7.519

2.  Protein phosphatase 1γ isoforms linked interactions in the brain.

Authors:  Sara L C Esteves; Luís Korrodi-Gregório; Cândida Z Cotrim; Paula J M van Kleeff; Sara C Domingues; Odete A B da Cruz e Silva; Margarida Fardilha; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2012-10-19       Impact factor: 3.444

Review 3.  Trafficking and proteolytic processing of APP.

Authors:  Christian Haass; Christoph Kaether; Gopal Thinakaran; Sangram Sisodia
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

4.  The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction.

Authors:  L Torroja; M Packard; M Gorczyca; K White; V Budnik
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

5.  Protein kinase C bound to the Golgi apparatus supports the formation of constitutive transport vesicles.

Authors:  P Westermann; M Knoblich; O Maier; C Lindschau; H Haller
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

6.  Protein phosphatase 1α interacting proteins in the human brain.

Authors:  Sara L C Esteves; Sara C Domingues; Odete A B da Cruz e Silva; Margarida Fardilha; Edgar F da Cruz e Silva
Journal:  OMICS       Date:  2012 Jan-Feb

7.  Tyr687 dependent APP endocytosis and Abeta production.

Authors:  Sandra Rebelo; Sandra Isabel Vieira; Hermann Esselmann; Jens Wiltfang; Edgar F da Cruz e Silva; Odete A B da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

8.  Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.

Authors:  Minji Kim; Jaehong Suh; Donna Romano; Mimy H Truong; Kristina Mullin; Basavaraj Hooli; David Norton; Giuseppina Tesco; Kathy Elliott; Steven L Wagner; Robert D Moir; K David Becker; Rudolph E Tanzi
Journal:  Hum Mol Genet       Date:  2009-07-15       Impact factor: 6.150

Review 9.  Targeting Abeta and tau in Alzheimer's disease, an early interim report.

Authors:  Todd E Golde; Leonard Petrucelli; Jada Lewis
Journal:  Exp Neurol       Date:  2009-08-27       Impact factor: 5.330

10.  Cyclopamine modulates γ-secretase-mediated cleavage of amyloid precursor protein by altering its subcellular trafficking and lysosomal degradation.

Authors:  Anna G Vorobyeva; Randall Lee; Sean Miller; Charles Longen; Michal Sharoni; Preeti J Kandelwal; Felix J Kim; Daniel R Marenda; Aleister J Saunders
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.